Olaf Prante Selected Research

BIBP 3226

3/2017	Prototypic 18F-Labeled Argininamide-Type Neuropeptide Y Y1R Antagonists as Tracers for PET Imaging of Mammary Carcinoma.
4/2015	Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olaf Prante Research Topics

Disease

31	Neoplasms (Cancer) 05/2022 - 05/2008
12	Prostatic Neoplasms (Prostate Cancer) 09/2020 - 01/2017
5	Thyroid Neoplasms (Thyroid Cancer) 01/2013 - 08/2006
4	Neoplasm Metastasis (Metastasis) 05/2022 - 08/2006
3	Carcinoma (Carcinomatosis) 10/2019 - 01/2016
3	Breast Neoplasms (Breast Cancer) 03/2017 - 04/2015
3	Substance-Related Disorders (Drug Abuse) 01/2017 - 05/2008
2	Obesity 05/2022 - 08/2015
2	Adenocarcinoma 01/2021 - 03/2017
2	Ewing Sarcoma (Sarcoma, Ewing) 06/2020 - 01/2020
2	Glioma (Gliomas) 09/2009 - 05/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Disease Progression 11/2020
1	Immunoglobulin G4-Related Disease 11/2020
1	Fibrosis (Cirrhosis) 11/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2019
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2016
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2016
1	Body Weight (Weight, Body) 08/2015
1	Basal Ganglia Diseases (Basal Ganglia Disease) 07/2014
1	Alcoholism (Alcohol Abuse) 03/2014
1	Mental Disorders (Mental Disorder) 03/2013
1	Colonic Neoplasms (Colon Cancer) 12/2012
1	Colorectal Neoplasms (Colorectal Cancer) 12/2012
1	Epilepsy (Aura) 01/2011
1	Partial Epilepsies (Epilepsy, Partial) 01/2011

Drug/Important Bio-Agent (IBA)

5	AntigensIBA 08/2020 - 01/2017
5	technetium 99m 1- (1- (2- (bis(carboxymethyl)amino)- 2- oxoethyl)- 1H- imidazol- 2- yl)- 2- ((1- (2- (bis(carboxymethyl)amino)- 2- oxoethyl)- 1H- imidazol- 2- yl)methyl)- 9,14- dioxo- 2,8,13,15- tetraazaoctadecane- 7,12,16,18- tetracarboxylic acid)IBA 08/2020 - 04/2018
5	LigandsIBA 02/2020 - 01/2017
5	Neurotensin Receptors (Neurotensin Receptor)IBA 01/2018 - 08/2010
4	Peptides (Polypeptides)IBA 11/2016 - 08/2010
3	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 08/2006
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2022 - 08/2006
3	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 08/2015
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2020
3	gallium 68 PSMA-11IBA 01/2020 - 10/2018
3	Neuropeptide YIBA 10/2019 - 04/2015
3	Pharmaceutical PreparationsIBA 08/2018 - 01/2011
3	Dopamine D3 ReceptorsIBA 01/2017 - 05/2008
3	IntegrinsIBA 01/2016 - 10/2010
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 07/2011 - 08/2006
3	Tyrosine (L-Tyrosine)FDA Link 09/2009 - 04/2007
3	Amino Acids FDA Link 07/2009 - 04/2007
2	Circulating Tumor DNAIBA 06/2020 - 01/2020
2	RadiopharmaceuticalsIBA 01/2020 - 01/2018
2	Prostate-Specific Antigen (Semenogelase)IBA 12/2019 - 10/2019
2	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 10/2019 - 10/2018
2	BIBP 3226IBA 03/2017 - 04/2015
2	PanobinostatIBA 01/2016 - 12/2012
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2015 - 04/2014
2	GlycopeptidesIBA 04/2015 - 02/2014
2	GlycoconjugatesIBA 11/2013 - 01/2013
1	PPAR gammaIBA 05/2022
1	Biomarkers (Surrogate Marker)IBA 05/2022
1	bisphenol AIBA 05/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Contrast MediaIBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 01/2021
1	Chelating AgentsIBA 12/2020
1	68Ga-FAPIIBA 11/2020
1	Antifibrotic AgentsIBA 11/2020
1	GlucocorticoidsIBA 11/2020
1	AndrogensIBA 08/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	ProdrugsIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	quinone methideIBA 01/2019
1	argininamideIBA 03/2017
1	2- (4- (4- chlorophenyl)piperazin- 1- ylmethyl)pyrazolo(1,5- a)- pyridineIBA 01/2017
1	Biological ProductsIBA 01/2017
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2017
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2016
1	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2016
1	Octreotide (Sandostatin)FDA LinkGeneric 11/2016
1	Therapeutic UsesIBA 01/2016
1	NeurotensinIBA 01/2016
1	Molecular Probes (Molecular Probe)IBA 01/2016
1	CholesterolIBA 08/2015
1	Triglycerides (Triacylglycerol)IBA 08/2015
1	Insulin (Novolin)FDA Link 08/2015
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 07/2014
1	PalladiumIBA 11/2013
1	SR 142948AIBA 11/2013
1	Dopamine Receptors (Dopamine Receptor)IBA 03/2013
1	Endothelins (Endothelin)IBA 01/2013
1	Death-Associated Protein KinasesIBA 12/2012
1	Small Interfering RNA (siRNA)IBA 12/2012
1	cyclic arginine-glycine-aspartic acid peptideIBA 10/2010
1	PeptoidsIBA 08/2010

Therapy/Procedure

10	Therapeutics 05/2022 - 01/2016
3	Radiotherapy 08/2020 - 04/2014
3	Aftercare (After-Treatment) 02/2020 - 04/2014
1	Castration 09/2020
1	Drug Therapy (Chemotherapy) 01/2020